End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.2 DKK | -.--% | +1.49% | -42.54% |
04-16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
04-12 | Curasight A/S Announces Board Changes | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CURASIGHT A/S | Other Biotechnology & Medical Research | -.--% | +1.49% | -42.54% | -26.62% | - | 28.26M | - | - | - |
- Stock Market
- Equities
- CURAS Stock
- Charts Curasight A/S
- Relative Strength Chart